2016
DOI: 10.1007/s10578-016-0694-8
|View full text |Cite
|
Sign up to set email alerts
|

Successful Treatment Response with Aripiprazole Augmentation of SSRIs in Refractory Obsessive–Compulsive Disorder in Childhood

Abstract: The aim of this study is to evaluate the aripiprazole augmentation of selective seratonine reuptake inhibitors (SSRIs) in children and adolescents with treatment-resistant OCD. Forty-eight children and adolescents (14 girls, 34 boys), who are non-responders to treatment with at least two types of SSRIs and CBT, were administered a 12-week of augmentation. Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS), and Clinical Global Impression-Severity and Improvement (CGI-S and CGI-I) sub-scales were used fo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
4
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 17 publications
(5 citation statements)
references
References 34 publications
0
4
0
1
Order By: Relevance
“…22 For treatment-refractory OCD, open-label trials and case studies have shown that augmentation of SSRIs with risperidone or aripiprazole can reduce OCD symptoms in children. [28][29][30] Table 1.…”
Section: What Types Of Interventions or Treatments Can Results In Cli...mentioning
confidence: 99%
“…22 For treatment-refractory OCD, open-label trials and case studies have shown that augmentation of SSRIs with risperidone or aripiprazole can reduce OCD symptoms in children. [28][29][30] Table 1.…”
Section: What Types Of Interventions or Treatments Can Results In Cli...mentioning
confidence: 99%
“…Previous studies showed that aripiprazole was effective as a monotherapy in children, aged between 10-12 years old (Ercan et al, 2015; O’Connor et al, 2005; Akyol Ardic et al, 2017). In the present study, all of the children had high scores at baseline CY-BOCS evaluations, and most of them had at least one comorbid psychiatric disorder.…”
Section: Discussionmentioning
confidence: 99%
“…Treatment of anxiety with SSRIs is wellknown. Some studies showed the beneficial results of augmentation of therapeutic effect of SSRIs by adding an aripiprazole in the treatment of obsessive compulsive disease (OCD) and depression (Akyol-Ardic et al, 2016;Sugawara, Sakamoto, Harada, Shimizu, & Ishigooka, 2016). Also aripiprazole monotherapy effective in the treatment of OCD (Connor, Payne, Gadde, Zhang, & Davidson, 2005).…”
Section: Discussionmentioning
confidence: 99%